Guaifenesin (API) Market Report – Research, Industry Analysis Reports and Market Demands

Global Guaifenesin (API) Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Guaifenesin (API) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Guaifenesin (API) Market Size Growth Rate by Product
- 1.4.2 98%-99%
- 1.4.3 >99%
1.5 Market by End User
- 1.5.1 Global Guaifenesin (API) Market Size Growth Rate by End User
- 1.5.2 Pharmaceuticals
- 1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Guaifenesin (API) Market Size
- 2.1.1 Global Guaifenesin (API) Revenue 2014-2025
- 2.1.2 Global Guaifenesin (API) Sales 2014-2025
2.2 Guaifenesin (API) Growth Rate by Regions
- 2.2.1 Global Guaifenesin (API) Sales by Regions
- 2.2.2 Global Guaifenesin (API) Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Guaifenesin (API) Sales by Manufacturers
- 3.1.1 Guaifenesin (API) Sales by Manufacturers
- 3.1.2 Guaifenesin (API) Sales Market Share by Manufacturers
- 3.1.3 Global Guaifenesin (API) Market Concentration Ratio (CR5 and HHI)
3.2 Guaifenesin (API) Revenue by Manufacturers
- 3.2.1 Guaifenesin (API) Revenue by Manufacturers (2014-2019)
- 3.2.2 Guaifenesin (API) Revenue Share by Manufacturers (2014-2019)
3.3 Guaifenesin (API) Price by Manufacturers
3.4 Guaifenesin (API) Manufacturing Base Distribution, Product Types
- 3.4.1 Guaifenesin (API) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Guaifenesin (API) Product Type
- 3.4.3 Date of International Manufacturers Enter into Guaifenesin (API) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Guaifenesin (API) Sales by Product
4.2 Global Guaifenesin (API) Revenue by Product
4.3 Guaifenesin (API) Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Guaifenesin (API) Breakdown Data by End User

6 North America

6.1 North America Guaifenesin (API) by Countries
- 6.1.1 North America Guaifenesin (API) Sales by Countries
- 6.1.2 North America Guaifenesin (API) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Guaifenesin (API) by Product
6.3 North America Guaifenesin (API) by End User

7 Europe

7.1 Europe Guaifenesin (API) by Countries
- 7.1.1 Europe Guaifenesin (API) Sales by Countries
- 7.1.2 Europe Guaifenesin (API) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Guaifenesin (API) by Product
7.3 Europe Guaifenesin (API) by End User

8 Asia Pacific

8.1 Asia Pacific Guaifenesin (API) by Countries
- 8.1.1 Asia Pacific Guaifenesin (API) Sales by Countries
- 8.1.2 Asia Pacific Guaifenesin (API) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Guaifenesin (API) by Product
8.3 Asia Pacific Guaifenesin (API) by End User

9 Central & South America

9.1 Central & South America Guaifenesin (API) by Countries
- 9.1.1 Central & South America Guaifenesin (API) Sales by Countries
- 9.1.2 Central & South America Guaifenesin (API) Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Guaifenesin (API) by Product
9.3 Central & South America Guaifenesin (API) by End User

10 Middle East and Africa

10.1 Middle East and Africa Guaifenesin (API) by Countries
- 10.1.1 Middle East and Africa Guaifenesin (API) Sales by Countries
- 10.1.2 Middle East and Africa Guaifenesin (API) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Guaifenesin (API) by Product
10.3 Middle East and Africa Guaifenesin (API) by End User

11 Company Profiles

12 Future Forecast

12.1 Guaifenesin (API) Market Forecast by Regions
- 12.1.1 Global Guaifenesin (API) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Guaifenesin (API) Revenue Forecast by Regions 2019-2025
12.2 Guaifenesin (API) Market Forecast by Product
- 12.2.1 Global Guaifenesin (API) Sales Forecast by Product 2019-2025
- 12.2.2 Global Guaifenesin (API) Revenue Forecast by Product 2019-2025
12.3 Guaifenesin (API) Market Forecast by End User
12.4 North America Guaifenesin (API) Forecast
12.5 Europe Guaifenesin (API) Forecast
12.6 Asia Pacific Guaifenesin (API) Forecast
12.7 Central & South America Guaifenesin (API) Forecast
12.8 Middle East and Africa Guaifenesin (API) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Guaifenesin (API) Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The global Guaifenesin (API) market is valued at 56 million US$ in 2018 and will reach 58 million US$ by the end of 2025, growing at a CAGR of 0.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Guaifenesin (API) market based on company, product type, end user and key regions.

This report studies the global market size of Guaifenesin (API) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Guaifenesin (API) in these regions.
This research report categorizes the global Guaifenesin (API) market by top players/brands, region, type and end user. This report also studies the global Guaifenesin (API) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

Market size by Product
98%-99%
>99%
Market size by End User
Pharmaceuticals
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Guaifenesin (API) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Guaifenesin (API) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Guaifenesin (API) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Guaifenesin (API) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Guaifenesin (API) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Guaifenesin (API) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.